Valeant receives FDA approval for secondary supplier of Methoxsalen - News-Medical.net

Valeant receives FDA approval for secondary businessperson of Methoxsalen News-Medical.net The FDA has approved the addition of a alternate supplier of Methoxsalen USP, an integral component of a treatment for the relief of moderate to severe psoriasis prescribed low the brand name Oxsoralen-Ultra® (methoxsalen) Capsules, USP, 10mg. and more » Link To Article